{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:19:07Z","timestamp":1790961547022,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["75N95019C00054"],"award-info":[{"award-number":["75N95019C00054"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.annemergmed.2023.03.025","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T01:03:48Z","timestamp":1683853428000},"page":"326-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-0549","authenticated-orcid":false,"given":"Ethan","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edouard","family":"Coupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Huntley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2023.03.025_bib1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016","volume":"319","author":"Jones","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib3","author":"Ahmad"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib4","first-page":"1","article-title":"National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014\u20132018","author":"Suen","year":"2021","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: trends in emergency department visits for suspected opioid overdoses\u2014United States, July 2016\u2013September 2017","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262136","article-title":"Emergency department utilization for substance use disorders and mental health conditions during COVID-19","volume":"17","author":"Venkatesh","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose","volume":"75","author":"Weiner","year":"2020","journal-title":"Annf Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib10","first-page":"e214","article-title":"Buprenorphine in the emergency department: randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal","volume":"65","author":"Srivastava","year":"2019","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajem.2019.158373","article-title":"Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program","volume":"38","author":"Kaucher","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib12","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ajem.2019.12.038","article-title":"A\u00a0novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers","volume":"38","author":"Kelly","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib13","doi-asserted-by":"crossref","unstructured":"D'Onofrio G, Edelman EJ, Hawk KF, et\u00a0al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder. JAMA Network Open. 2023 March 30;6.","DOI":"10.1001\/jamanetworkopen.2023.5439"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.annemergmed.2019.08.420","article-title":"Treating opioid withdrawal with buprenorphine in a community hospital emergency department: an outreach program","volume":"75","author":"Edwards","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.21209","article-title":"Trends in the use of buprenorphine in US emergency departments, 2002-2017","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib20","article-title":"User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial","volume":"377","author":"Melnick","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib21","unstructured":"Consolidated Appropriations Act. H.R. 2617 (ENR). USA2023."},{"key":"10.1016\/j.annemergmed.2023.03.025_bib23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s11606-010-1377-y","article-title":"The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand\/improve buprenorphine treatment","volume":"25","author":"Egan","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib24","series-title":"Use of medication-assisted treatment in emergency departments","year":"2021"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18511","article-title":"Participation in a hospital incentive program for follow-up treatment for opioid use disorder","volume":"3","author":"Kilaru","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.annemergmed.2022.05.010","article-title":"Models for implementing emergency department\u2013initiated buprenorphine with referral for ongoing medication treatment at emergency department discharge in diverse academic centers","volume":"80","author":"Whiteside","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsat.2019.06.013","article-title":"Emergency department-based peer support for opioid use disorder: emergent functions and forms","volume":"108","author":"McGuire","year":"2020","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jsat.2018.07.013","article-title":"Peer navigation and take-home naloxone for opioid overdose emergency department patients: preliminary patient outcomes","volume":"94","author":"Samuels","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108595","article-title":"Evaluation of an emergency department-based opioid overdose survivor intervention: difference-in-difference analysis of electronic health record data to assess key outcomes","volume":"221","author":"Watson","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25582","article-title":"Effect of a peer-led behavioral intervention for emergency department patients at high risk of fatal opioid overdose: a randomized clinical trial","volume":"5","author":"Beaudoin","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib33","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/emp2.12208","article-title":"Emergency medical services targeting opioid user disorder: an exploration of current out-of-hospital post-overdose interventions","volume":"1","author":"Champagne-Langabeer","year":"2020","journal-title":"J\u00a0Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib34","article-title":"Emergency department-initiated buprenorphine protocols: a national evaluation","volume":"2","author":"Guo","year":"2021","journal-title":"J\u00a0Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.17128","article-title":"High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder","volume":"4","author":"Herring","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib36","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.74018","article-title":"Buprenorphine\u2013naloxone \u201cmicrodosing\u201d: an alternative induction approach for the treatment of opioid use disorder in the wake of North America\u2019s increasingly potent illicit drug market","volume":"192","author":"Randhawa","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.6108","article-title":"Incidence of precipitated withdrawal during a muti-site emergency department-initiated buprenorphine clinical trial in the era of fentanyl","volume":"6","author":"D\u2019Onofrio","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106359","article-title":"The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: project ED Innovation","volume":"104","author":"D'Onofrio","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annemergmed.2019.07.021","article-title":"One-year mortality after emergency department visit for nonfatal opioid poisoning: a population-based analysis","volume":"75","author":"Leece","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.annemergmed.2022.01.042","article-title":"Subsequent buprenorphine treatment following emergency physician buprenorphine prescription fills a national assessment 2019 to 2020","volume":"79","author":"Stein","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5811\/westjem.2020.7.46079","article-title":"Beyond buprenorphine: models of follow-up care for opioid use disorder in the emergency department","volume":"21","author":"Martin","year":"2020","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2017.01.048","article-title":"The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting","volume":"176","author":"Eibl","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib45","first-page":"138","article-title":"Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment (MAT) for opioid use disorder: a 2-year retrospective data analysis","volume":"11","author":"Zheng","year":"2017","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.annemergmed.2021.05.024","article-title":"Rapid adoption of low-threshold buprenorphine treatment at California emergency departments participating in the CA bridge program","volume":"78","author":"Snyder","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5811\/westjem.2022.3.54680","article-title":"Implementing a novel statewide network to support emergency department-initiated buprenorphine treatment","volume":"23","author":"Clemency","year":"2022","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.03.025_bib50","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/add.13900","article-title":"Cost-effectiveness of emergency department-initiated treatment for opioid dependence","volume":"112","author":"Busch","year":"2017","journal-title":"Addiction"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064423002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064423002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:49:14Z","timestamp":1759294154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064423002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0196064423002172"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2023.03.025","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2023.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}